Orasis Pharmaceuticals
Dr. Lindstrom is a board-certified ophthalmologist and internationally recognized leader in ophthalmology. He is the founder and attending surgeon at Minnesota Eye Consultants, adjunct professor emeritus at the University of Minnesota department of ophthalmology, a trustee of the University of Minnesota Foundation, visiting professor at University of California Irvine, Gavin Herbert Eye Institute and global chief medical editor of Ocular Surgery News. He holds over 40 patents for ophthalmology innovations.
Dr. Lindstrom completed his medical degree and residency at the University of Minnesota Medical School followed by two years of fellowship training in cornea, external disease, cataract surgery, refractive surgery and glaucoma.
This person is not in the org chart
This person is not in any offices
Orasis Pharmaceuticals
2 followers
Orasis is an emerging ophthalmic pharmaceutical company with the goal of making near vision clear again. They are committed to the Ophthalmology and Optometry segments because they know that presbyopia is ubiquitous. By virtue of their first in class formulation, Orasis is well-positioned to be first-line therapy in this emerging category by addressing a significant unmet need for patients.